Cameroon Ministry of Health (MOH)
Feasibility, effectiveness and acceptability of a data warehouse of five PCT NTDs into DHIS2 in Cameroon
A formative study to quantify and describe implementation challenges in integrating NTD data into a data warehouse using the national DHIS2 platform and make recommendations for program improvements
Reaching semi-nomadic groups using a test and treat (with doxycycline) strategy in a challenging onchocerciasis focus in West Region of Cameroon
- Is mobile outreach with a doxycycline test and treat strategy (TTd) an effective strategy in reducing onchocerciasis prevalence and intensity of infection amongst hard-to-reach nomadic groups in Massangam health area (HA)?
- What is the variation in prevalence of onchocerciasis and intensity of infection (community microfilaria load (CML)) in the different age and sex groups of hard-to-reach nomad community in the Massangam HA?
- What was the coverage of ivermectin mass drug administration in the nomad population with respect to the last round of ivermectin MDA?
- What is the cost of the mobile outreach strategy in this context, per person screened and treated?
Concerted Action on Female Genital Schistosomiasis and Gynecological Diseases in Cameroon: Integrating Precision Mapping of Urogenital Schistosomiasis with Rapid Assessment of FGS for Better Community Management of Gynecological Diseases
This proof of concept study will take place over a 10-month period. They aim to compare the feasibility and acceptability of mobile gynecological clinics versus traditional, static health posts. The primary research question, Where urogenital schistosomiasis is endemic, can a static health outpost versus a mobile clinic deliver better diagnosis and treatmnet of FGS, HIV, HPV, and cervical cancer in an acceptable and cost-effective manner to women (14-30 years), will be answered through the following activities:
- Development of a consortium on FGS bringing together high-profile researchers, policy makers, program implementers, and health professionals
- Training of health professionals (nurses, physicians, community health workers) with follow up sessions to raise awareness and diagnostic capabilities through colposcopic imagery. Health workers in remote areas will utilize telehealth to transmit images for quality checks by a specialist. The team will measure the % correlation between field results and telemedicine results to determine feasibility.
- Precision mapping in select districts to determine areas with the highest schistosomiasis prevalence through parasitological surveys
- Pilot test mobile service delivery for FGS, HIV, HPV, and other common gynecological issues in two of the four districts. This will include a cost analysis to make a business case for scalability.
Concerted Action on Female Genital Schistosomiasis and Gynecological Diseases in Cameroon: Integrating Precision Mapping of Urogenital Schistosomiasis with Rapid Assessment of FGS for Better Community Management of Gynecological Diseases
This proof of concept study will take place over a 10-month period. They aim to compare the feasibility and acceptability of mobile gynecological clinics versus traditional, static health posts. The primary research question, Where urogenital schistosomiasis is endemic, can a static health outpost versus a mobile clinic deliver better diagnosis and treatmnet of FGS, HIV, HPV, and cervical cancer in an acceptable and cost-effective manner to women (14-30 years), will be answered through the following activities:
- Development of a consortium on FGS bringing together high-profile researchers, policy makers, program implementers, and health professionals
- Training of health professionals (nurses, physicians, community health workers) with follow up sessions to raise awareness and diagnostic capabilities through colposcopic imagery. Health workers in remote areas will utilize telehealth to transmit images for quality checks by a specialist. The team will measure the % correlation between field results and telemedicine results to determine feasibility.
- Precision mapping in select districts to determine areas with the highest schistosomiasis prevalence through parasitological surveys
- Pilot test mobile service delivery for FGS, HIV, HPV, and other common gynecological issues in two of the four districts. This will include a cost analysis to make a business case for scalability.
Concerted Action on Female Genital Schistosomiasis and Gynecological Diseases in Cameroon: Integrating Precision Mapping of Urogenital Schistosomiasis with Rapid Assessment of FGS for Better Community Management of Gynecological Diseases
This proof of concept study will take place over a 10-month period. They aim to compare the feasibility and acceptability of mobile gynecological clinics versus traditional, static health posts. The primary research question, Where urogenital schistosomiasis is endemic, can a static health outpost versus a mobile clinic deliver better diagnosis and treatmnet of FGS, HIV, HPV, and cervical cancer in an acceptable and cost-effective manner to women (14-30 years), will be answered through the following activities:
- Development of a consortium on FGS bringing together high-profile researchers, policy makers, program implementers, and health professionals
- Training of health professionals (nurses, physicians, community health workers) with follow up sessions to raise awareness and diagnostic capabilities through colposcopic imagery. Health workers in remote areas will utilize telehealth to transmit images for quality checks by a specialist. The team will measure the % correlation between field results and telemedicine results to determine feasibility.
- Precision mapping in select districts to determine areas with the highest schistosomiasis prevalence through parasitological surveys
- Pilot test mobile service delivery for FGS, HIV, HPV, and other common gynecological issues in two of the four districts. This will include a cost analysis to make a business case for scalability.
Evaluation of LF diagnostic Tools in Loa-Endemic Areas
To assess the specificity of diagnostic tools in Loa co-endemic areas and to conduct a prospective assessment of the impact of ALB MDA and Vector control on malaria, LF and STH indicators.
Evaluation of CCA urine-tests for diagnosis of Schistosoma guineensis infection in Cameroon
To determine if the circulating cathodic antigen (CCA) rapid diagnostic test is as effective as the Kato-Katz (KK) test in diagnosing S. guinensis
LFTAS + Biplex + DBS in Oncho endemic areas in Cameroon
To assess if transmission assessment surveys (TAS) for lymphatic filariasis (LF) are a feasible platform to integrate transmission assessment for onchocerciasis, using the same age group (6-7 years old) and the same prevalence threshold (<2%) that the LF programs utilize.
1. To perform the TAS for stopping LF MDA and use it as platform for Oncho impact assessment.
2. To assess the level of endemicity of Oncho following at least five rounds of MDA in hypo, meso and hyper endemic districts.
3. To study the performance of the Wb123/Ov16 Biplex rapid diagnostic test (RDT) to assess Oncho and LF transmission interruption.
Reaching semi-nomadic groups using a test and treat (with doxycycline) strategy in a challenging onchocerciasis focus in West Region of Cameroon
- Is mobile outreach with a doxycycline test and treat strategy (TTd) an effective strategy in reducing onchocerciasis prevalence and intensity of infection amongst hard-to-reach nomadic groups in Massangam health area (HA)?
- What is the variation in prevalence of onchocerciasis and intensity of infection (community microfilaria load (CML)) in the different age and sex groups of hard-to-reach nomad community in the Massangam HA?
- What was the coverage of ivermectin mass drug administration in the nomad population with respect to the last round of ivermectin MDA?
- What is the cost of the mobile outreach strategy in this context, per person screened and treated?
Concerted Action on Female Genital Schistosomiasis and Gynecological Diseases in Cameroon: Integrating Precision Mapping of Urogenital Schistosomiasis with Rapid Assessment of FGS for Better Community Management of Gynecological Diseases
This proof of concept study will take place over a 10-month period. They aim to compare the feasibility and acceptability of mobile gynecological clinics versus traditional, static health posts. The primary research question, Where urogenital schistosomiasis is endemic, can a static health outpost versus a mobile clinic deliver better diagnosis and treatmnet of FGS, HIV, HPV, and cervical cancer in an acceptable and cost-effective manner to women (14-30 years), will be answered through the following activities:
- Development of a consortium on FGS bringing together high-profile researchers, policy makers, program implementers, and health professionals
- Training of health professionals (nurses, physicians, community health workers) with follow up sessions to raise awareness and diagnostic capabilities through colposcopic imagery. Health workers in remote areas will utilize telehealth to transmit images for quality checks by a specialist. The team will measure the % correlation between field results and telemedicine results to determine feasibility.
- Precision mapping in select districts to determine areas with the highest schistosomiasis prevalence through parasitological surveys
- Pilot test mobile service delivery for FGS, HIV, HPV, and other common gynecological issues in two of the four districts. This will include a cost analysis to make a business case for scalability.
LFTAS + Biplex + DBS in Oncho endemic areas in Cameroon
To assess if transmission assessment surveys (TAS) for lymphatic filariasis (LF) are a feasible platform to integrate transmission assessment for onchocerciasis, using the same age group (6-7 years old) and the same prevalence threshold (<2%) that the LF programs utilize.
1. To perform the TAS for stopping LF MDA and use it as platform for Oncho impact assessment.
2. To assess the level of endemicity of Oncho following at least five rounds of MDA in hypo, meso and hyper endemic districts.
3. To study the performance of the Wb123/Ov16 Biplex rapid diagnostic test (RDT) to assess Oncho and LF transmission interruption.
Les facteurs explicatifs de l’accès aux soins de santé de la filariose lymphatique chez les réfugiés des camps de Lolo et Mbile, dans la région de l’Est du Cameroun
1. What is the level of knowledge of lymphatic filariasis and its symptoms among refugees?
2. What is the prevalence of LF symptoms among refugees?
3. What are the explanatory factors for health care use among refugees?
4. What factors explain access to health care for lymphatic filariasis in refugees?
A Collaboration Model Between the National NTD Control Programs and Traditional Healers to Detect Additional Cases of Lymphatic filariasis, Onchocerciasis and Schistosomiasis In Cameroon
1- What is the effect of linking NTD control programs with traditional healers in an effort to detect additional cases of schistosomiasis, Onchocerciasis, and Lymphatic filariasis in two rural health districts in Cameroon: Bafia (Center region) and Bankim (Adamaoua region).
2- Will the traditional healers properly use the screening tools after training by NTD control program personnel?
3- Will the screening tools used by the traditional healers show clinical effectiveness so the prevalence of schistosomiasis, Onchocerciasis, and Lymphatic filariasis during our intervention?